Thus, we next determined by IHC whether Granzyme B was being affected by RFA treatment alone or in combination with AB680 in the long term (Post 10D) and compared the results with a standard KPC subcutaneous tumor grown up to 10 days (Control) which received no treatment (Figures 3A, C). The gene discussed is GZMB; the disease is neoplasm.